Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.
Ernest Kawka

Ernest Kawka Ernest Kawka is PhRMA’s deputy vice president for international intellectual property. Previously, he worked for industry’s international trade association in Geneva, Switzerland focusing on intellectual property and trade policies. He received a law degree from University of New Hampshire School of Law.

Recent Posts

U.S. must address IP and market access barriers abroad to protect American innovation

By Ernest Kawka  |    January 31, 2023
PhRMA recently submitted comments to the Office of the U.S. Trade Representative (USTR)’s 2023 Special 301 Report. The comments highlight foreign government actions and policies that undermine...   Read More

Biden Administration details inadequate protection of American intellectual property and foreign barriers to innovation abroad

By Ernest Kawka  |    April 29, 2022
More than two years into the COVID-19 pandemic, the world has witnessed the immense value of biopharmaceutical innovation. With numerous safe and effective vaccines and treatments developed in record...   Read More

Protecting U.S. innovation abroad to support economic and pandemic recovery

By Ernest Kawka  |    February 1, 2022
PhRMA’s recently submitted comments to the Office of the U.S. Trade Representative (USTR)’s 2022 Special 301 Report reinforce how the United States can confirm its strong commitment to defend...   Read More

American leadership on innovation policy is essential to global health progress

By Ernest Kawka  |    May 4, 2021
Over the last year, the world has witnessed the importance of strong innovation policies as intellectual property protection and market access policies facilitated the research, development and...   Read More

Search the Catalyst

View Posts by Topic

see all

View Posts by Contributor

View Posts by Date

see all

Subscribe to Email Updates